Mapping large numbers of results may take a few moments.
Search Results
Showing 51 - 64 of 64 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company PeriGen Inc. | Activity: Support and Related | Company Description PeriGen develops fetal monitoring and clinical analytic systems that employ pattern-recognition and obstetric technology to aid obstetric decision-making at the point of care. | Location Cary | |
Company Quotient Biodiagnostics Inc. | Activity: Support and Related | Company Description Quotient manufactures and sells blood banking reagents and other immunohematology products to hospitals and blood banks. The Chapel Hill office deals with North American sales, techincal support, logistics and marketing. | Location Chapel Hill | |
Company Resonantia Diagnostics | Activity: Research and Development | Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. | Location Durham | |
Company Revvity | Activity: Research and Development | Company Description Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development. | Location Durham | |
Company Salvus LLC | Activity: Research and Development | Company Description Salvus provides a handheld chemical and biological interferometric detector, a device which has the ability to rapidly identify chemicals, pathogens and viruses in liquid, air or surface environments. | Location Charlotte | |
Company Sanesco International Inc. | Activity: Research and Development | Company Description Sanesco develops clinical tools for healthcare providers, such as neuroendocrine analytical testing, nutritional support formulas and patient-centered clinical review. The NeuroLab division conducts research and development of in vitro diagnostic tools. | Location Arden | |
Company Sapere Bio Inc. | Activity: Research and Development | Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. | Location Research Triangle Park | |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte | |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |